Evotec Biologics, the biologics segment of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: ...

Prior Phase 3 studies showed positive benefits in increasing unstimulated whole saliva secretionAinos aims to complete all regulatory approvals for the study in Q4 2024SAN DIEGO, CA / ACCESSWIRE / ...

Tempo Manufacturing Cloud Seamless processing through every layer of your manufacturing ecosystem in one platform by combining historically distributed systems ? Manufacturing Execution System (MES), ...

KELOWNA, BC and MELBOURNE, AUSTRALIA / ACCESSWIRE / September 23, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading Canadian producer of award-winning, ...

MISSISSAUGA, ON / ACCESSWIRE / September 23, 2024 / Science & Humans (S&H), Canada's leading platform for hormone health, is excited to announce the appointment of Karim (Matt) Nassar as Chief Growth ...

New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine ProceduresBELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), ...

IPOPentixapharm Holding AG Sets Price Range for Planned IPO 23.09.2024 / 12:15 CET/CESTThe issuer is solely responsible for the content of this announcement.ADVERTISEMENTNOT FOR DISTRIBUTION OR ...

ANGLE ANNOUNCES NEXT GENERATION SEQUENCING ASSAY AGREEMENT WITH NUPROBEOption for exclusive licence to highly sensitive NGS assay for use with CTCs and dual analysis of CTCs with ctDNACombining the ...

Miscellaneous23-Sep-2024 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Announces $2 ...

Each year, the CDC estimates that around 385,000 healthcare workers in the United States suffer from needlestick and ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...

The cell line development market size is expected to experience a 10.3% CAGR from 2024 to 2032, driven by an increase in ...